Distinct pattern of TP53 mutations in squamous cell carcinoma of the esophagus in Iran

被引:51
|
作者
Sepehr, A
Tanière, P
Martel-Planche, G
Zia'ee, AA
Rastgar-Jazii, F
Yazdanbod, M
Etemad-Moghadam, G
Kamangar, F
Saidi, F
Hainaut, P
机构
[1] IARC, Grp Mol Carcinogenesis, F-69008 Lyon, France
[2] Univ Tehran, Inst Biochem & Biophys, Tehran, Iran
[3] NRCGEB, Tehran, Iran
[4] Univ Tehran Med Sci, Dept Surg, Tehran, Iran
[5] Iran Mehr Hosp, Dept Pathol, Tehran, Iran
[6] Iran Mehr Hosp, Dept Surg, Tehran, Iran
[7] Johns Hopkins Univ, Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA
关键词
esophagus; neoplasms; Iran; p53; COX-2;
D O I
10.1038/sj.onc.1204912
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Extremely high rates of squamous cell carcinoma of the esophagus (SCCE), are observed in Iran,, reflecting unknown, genetic and/or epidemiological risk factors. Among genetic alterations, in SCCE,: TP53: mutations are the most frequent, vary among populations, and may provide clues on etiological mechanisms. We have analysed mutations in TP53 (exons 5-8): in 98 SCCE from Iran by temporal temperature get electrophoresis and direct sequencing. We found 58, mutations, in 49 patients, (50%,), with a high prevalence of C to T transitions at CpG dinucleotides (29.3%). The TP53 mutation pattern in Iran was significantly different from that observed in SCCEs from high incidence areas of China and Western Europe (P=0.007)., Moreover, the prevalence of mutations at A:T base pairs, (transitions and transversions) was higher in men than in women (38.7%, vs 11.1%, P=0.033). COX-2 overexpression was, detected in 69% of the cases evaluated (24/35), without significant association with TP53, mutation. Accumulation of nitrotyrosine, a marker of protein damage by excess, levels of nitric oxide, was observed in tumor cells, in six of 16 cases analysed. These results are consistent with the hypothesis that several factors are involved in TP53 mutagenesis, in Iran., These factors include a baseline of chronic inflammatory stress, which may have a multiplicative impact on the sensitivity of esophageal cells to exogenous factors of risk.
引用
收藏
页码:7368 / 7374
页数:7
相关论文
共 50 条
  • [31] CHARACTERIZATION OF SQUAMOUS CELL CARCINOMAS OF THE SUPRAGLOTTIC LARYNX WITH OR WITHOUT MUTATIONS IN TP53
    Eriksen, J. G.
    Lassen, P.
    Alsner, J.
    Overgaard, J.
    RADIOTHERAPY AND ONCOLOGY, 2008, 88 : S151 - S152
  • [32] Association between copper excess, zinc deficiency and TP53 mutations in squamous cell carcinoma of esophagus from Kashmir valley, a high risk area
    Mir, M. M.
    Dar, N. A.
    Salam, I.
    Shah, Z. A.
    Shah, A.
    CLINICAL CHEMISTRY, 2007, 53 (06) : A110 - A110
  • [33] TP53 and CDKN2a Mutations in Never-Smoker Oral Tongue Squamous Cell Carcinoma
    Heaton, Chase M.
    Durr, Megan L.
    Tetsu, Osamu
    van Zante, Annemieke
    Wang, Steven J.
    LARYNGOSCOPE, 2014, 124 (07): : E267 - E273
  • [34] Oral squamous cell carcinoma of the tongue dorsum with multiple cancer-associated mutations in the TP53 gene
    Yamasaki, Sachiko
    Tani, Ryouji
    Sakurai, Shigeru
    Toratani, Shigeaki
    Okamoto, Tetsuji
    ORAL ONCOLOGY, 2020, 109
  • [35] High-Risk TP53 Mutations Are Associated with Extranodal Extension in Oral Cavity Squamous Cell Carcinoma
    Sandulache, Vlad C.
    Michikawa, Chieko
    Kataria, Pranav
    Gleber-Netto, Frederico O.
    Bell, Diana
    Trivedi, Sanchit
    Rao, Xiayu
    Wang, Jing
    Zhao, Mei
    Jasser, Samar
    Myers, Jeffrey N.
    Pickering, Curtis R.
    CLINICAL CANCER RESEARCH, 2018, 24 (07) : 1727 - 1733
  • [36] Differentiated vulvar intraepithelial neoplasia contains Tp53 mutations and is genetically linked to vulvar squamous cell carcinoma
    Pinto, Alvaro P.
    Miron, Alexander
    Yassin, Yosuf
    Monte, Nicolas
    Woo, Terri Y. C.
    Mehra, Karishma K.
    Medeiros, Fabiola
    Crum, Christopher P.
    MODERN PATHOLOGY, 2010, 23 (03) : 404 - 412
  • [37] Prognostic significance of TP53 mutations ion oral squamous cell carcinoma with human papilloma virus infection
    Kozomara, R. J.
    Brankovic-Magic, M. V.
    Jovic, N. R.
    Stosic, S. M.
    Magic, Z. M.
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2007, 22 (04): : 252 - 257
  • [38] PTEN and TP53 Mutations in Oncocytic Follicular Carcinoma
    Shuanzeng Wei
    Virginia A. LiVolsi
    Kathleen T. Montone
    Jennifer J. D. Morrissette
    Zubair W. Baloch
    Endocrine Pathology, 2015, 26 : 365 - 369
  • [39] PTEN and TP53 Mutations in Oncocytic Follicular Carcinoma
    Wei, Shuanzeng
    LiVolsi, Virginia A.
    Montone, Kathleen T.
    Morrissette, Jennifer J. D.
    Baloch, Zubair W.
    ENDOCRINE PATHOLOGY, 2015, 26 (04) : 365 - 369
  • [40] THE SPECTRUM OF TP53 MUTATIONS IN BLADDER-CARCINOMA
    WILLIAMSON, MP
    ELDER, PA
    KNOWLES, MA
    GENES CHROMOSOMES & CANCER, 1994, 9 (02): : 108 - 118